Introduction to protein engineering MCQs With Answer
Protein engineering integrates biochemistry, molecular biology and computational design to modify protein structure and function for therapeutic and industrial applications. This concise introduction for B. Pharm students covers core concepts—protein structure, enzyme kinetics, mutagenesis methods (site-directed, error-prone PCR), directed evolution, rational design, phage display, expression systems, post-translational modifications, stability optimization, and assays for activity and binding. Emphasis is placed on drug design, biosimilars, biopharmaceutical production, and regulatory considerations. These multiple-choice questions (MCQs) with answers reinforce practical knowledge required for formulation, bioprocessing, and novel therapeutic development. Now let’s test your knowledge with 30 MCQs on this topic.
Q1. What is the primary goal of protein engineering in pharmaceutical development?
- To sequence the genome of therapeutic organisms
- To design and modify proteins to enhance therapeutic properties
- To create synthetic DNA for vaccines
- To develop new small-molecule drugs exclusively
Correct Answer: To design and modify proteins to enhance therapeutic properties
Q2. Which technique is commonly used for introducing specific amino acid changes at a chosen site?
- Random mutagenesis by UV light
- Site-directed mutagenesis
- Mass spectrometry
- Western blotting
Correct Answer: Site-directed mutagenesis
Q3. Directed evolution primarily relies on which two iterative processes?
- Cloning and sequencing
- Mutation and selection/screening
- Protein purification and crystallization
- In silico docking and molecular dynamics
Correct Answer: Mutation and selection/screening
Q4. Which expression system is often preferred for producing therapeutic monoclonal antibodies?
- Escherichia coli
- Saccharomyces cerevisiae
- CHO (Chinese hamster ovary) cells
- Plant chloroplasts
Correct Answer: CHO (Chinese hamster ovary) cells
Q5. Phage display is a method used to:
- Measure enzyme kinetics in vivo
- Display peptide or protein variants on bacteriophage for ligand selection
- Sequence antibody genes directly from serum
- Encode proteins into plasmids for bacterial expression only
Correct Answer: Display peptide or protein variants on bacteriophage for ligand selection
Q6. Which computational approach predicts protein structures or designs new sequences?
- Polymerase chain reaction
- Rosetta or homology modeling
- ELISA
- Isoelectric focusing
Correct Answer: Rosetta or homology modeling
Q7. Error-prone PCR is most useful when the goal is to:
- Create a single targeted amino acid substitution
- Introduce a library of random mutations across a gene
- Precisely delete large genomic regions
- Measure protein stability by calorimetry
Correct Answer: Introduce a library of random mutations across a gene
Q8. Which post-translational modification is critical for many therapeutic glycoproteins’ activity and half-life?
- Phosphorylation
- Glycosylation
- Methylation
- Lipidation
Correct Answer: Glycosylation
Q9. When improving enzyme thermostability, which strategy is commonly employed?
- Removing all disulfide bonds
- Introducing stabilizing mutations such as proline substitutions and salt bridges
- Increasing the number of hydrophobic residues on the surface
- Reducing the molecular weight drastically
Correct Answer: Introducing stabilizing mutations such as proline substitutions and salt bridges
Q10. Which assay is commonly used to quantify enzyme catalytic efficiency?
- Western blot
- Kinetic measurement of Km and Vmax
- Isoelectric focusing
- SDS-PAGE
Correct Answer: Kinetic measurement of Km and Vmax
Q11. Alanine scanning mutagenesis is primarily used to:
- Determine effects of individual residues on protein stability or binding by systematic substitution with alanine
- Insert glycosylation sites into a protein
- Label proteins with fluorescent probes
- Amplify genes for cloning
Correct Answer: Determine effects of individual residues on protein stability or binding by systematic substitution with alanine
Q12. Codon optimization for expression in E. coli aims to:
- Alter the protein’s amino acid sequence
- Improve translational efficiency by matching codon usage to host tRNA abundance
- Increase glycosylation
- Introduce post-translational modifications
Correct Answer: Improve translational efficiency by matching codon usage to host tRNA abundance
Q13. Which analytical method provides high-resolution structural information about proteins?
- NMR spectroscopy and X-ray crystallography
- ELISA
- SDS-PAGE
- UV-Vis spectrophotometry
Correct Answer: NMR spectroscopy and X-ray crystallography
Q14. For screening large variant libraries, which technique enables rapid single-cell sorting based on binding or activity?
- Gel electrophoresis
- Fluorescence-activated cell sorting (FACS)
- Standard plate reader only
- Mass spectrometry
Correct Answer: Fluorescence-activated cell sorting (FACS)
Q15. Which factor is most important when designing a therapeutic protein to reduce immunogenicity?
- Maximizing hydrophobic surface exposure
- Humanizing sequences and removing T-cell epitopes
- Adding bacterial tags for purification
- Increasing protein aggregation propensity
Correct Answer: Humanizing sequences and removing T-cell epitopes
Q16. Which technique couples genotype and phenotype for selection of improved proteins?
- Southern blotting
- Phage display or yeast display
- ELISA without linkage
- Spectrophotometric enzyme assays only
Correct Answer: Phage display or yeast display
Q17. Which parameter describes protein stability as the temperature where 50% of protein is unfolded?
- KM
- Tm (melting temperature)
- pI
- Isoelectric point
Correct Answer: Tm (melting temperature)
Q18. In rational design of a binding interface, which information is most useful?
- Primary amino acid sequence only
- High-resolution 3D structure of the protein-ligand complex
- Cell growth rate data
- Generic codon usage tables
Correct Answer: High-resolution 3D structure of the protein-ligand complex
Q19. Which modification can improve a protein drug’s serum half-life?
- Increasing protease-sensitive sites
- PEGylation or Fc-fusion
- Removing glycosylation sites
- Adding degradation tags
Correct Answer: PEGylation or Fc-fusion
Q20. What is the role of molecular chaperones in recombinant protein expression?
- They degrade recombinant proteins
- They assist in proper protein folding and reduce aggregation
- They truncate proteins post-translationally
- They glycosylate proteins in bacteria
Correct Answer: They assist in proper protein folding and reduce aggregation
Q21. Which sequencing technology is most useful to analyze diversity of mutant libraries after selection?
- Sanger sequencing only
- Next-generation sequencing (NGS)
- Western blot analysis
- Edman degradation
Correct Answer: Next-generation sequencing (NGS)
Q22. In antibody engineering, “humanization” refers to:
- Converting human antibodies into mouse antibodies
- Altering non-human antibody sequences to resemble human frameworks while retaining antigen binding
- Adding sugar moieties to antibodies
- Fusing antibodies to toxins
Correct Answer: Altering non-human antibody sequences to resemble human frameworks while retaining antigen binding
Q23. Which parameter indicates catalytic efficiency combining affinity and turnover?
- kcat/Km
- IC50
- Molecular weight
- pKa
Correct Answer: kcat/Km
Q24. What is the main advantage of cell-free protein synthesis systems in engineering?
- They always produce glycosylated proteins
- Rapid expression and screening without cell viability constraints
- Unlimited folding capacity equivalent to mammalian cells
- They eliminate the need for DNA templates
Correct Answer: Rapid expression and screening without cell viability constraints
Q25. Which method can identify residues critical for ligand binding by systematic randomization and selection?
- Site-directed alanine scanning only
- Combinatorial library screening with deep sequencing
- UV-visible spectroscopy
- Isoelectric focusing
Correct Answer: Combinatorial library screening with deep sequencing
Q26. Why is aggregation a major concern for biopharmaceutical proteins?
- Aggregates improve therapeutic potency
- Aggregates can reduce efficacy and increase immunogenicity
- Aggregates lower production costs
- Aggregation makes proteins more soluble
Correct Answer: Aggregates can reduce efficacy and increase immunogenicity
Q27. In rational enzyme redesign, substituting which residue often increases rigidity and can stabilize local structure?
- Glycine to proline
- Tryptophan to alanine
- Serine to threonine
- Leucine to isoleucine
Correct Answer: Glycine to proline
Q28. Which regulatory consideration is critical for engineered protein therapeutics?
- Demonstrating consistent manufacture, purity, potency, and safety including immunogenicity assessment
- Only labeling color is regulated
- No documentation of host cell proteins is necessary
- Regulations do not apply to biosimilars
Correct Answer: Demonstrating consistent manufacture, purity, potency, and safety including immunogenicity assessment
Q29. Which approach integrates machine learning to predict beneficial mutations in protein engineering?
- Classical PCR without data
- Data-driven sequence-to-function models trained on experimental datasets
- Manual trial-and-error without computational tools
- Only classical homology modeling with no statistics
Correct Answer: Data-driven sequence-to-function models trained on experimental datasets
Q30. Which purification tag is commonly used to facilitate affinity purification of recombinant proteins?
- GFP tag only for purification
- His-tag (polyhistidine)
- Ribosomal RNA tag
- Ubiquitin degradation tag
Correct Answer: His-tag (polyhistidine)

I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com

